# EDGAR Filing Document

**Accession Number:** 0001861841
**File Stem:** 0001213900-25-074473
**Filing Date:** 2025-8
**Character Count:** 6538
**Document Hash:** 49aeff30ec944ea73a8055153feba342
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-074473.hdr.sgml**: 20250812

**ACCESSION NUMBER**: 0001213900-25-074473

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20250811

**FILED AS OF DATE**: 20250812

**DATE AS OF CHANGE**: 20250811

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Arbe Robotics Ltd.
- **CENTRAL INDEX KEY:** 0001861841
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40884
- **FILM NUMBER:** 251203404

**BUSINESS ADDRESS:**
- **STREET 1:** 107 HA'HASHMONAIM ST
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6713321
- **BUSINESS PHONE:** 972.73.7969804

**MAIL ADDRESS:**
- **STREET 1:** 107 HA'HASHMONAIM ST
- **CITY:** TEL AVIV
- **STATE:** L3
- **ZIP:** 6713321

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of August 2025**

**Commission File Number: 001-40884**

**ARBE ROBOTICS LTD.**

(Translation of registrant's name into English)

**HaHashmonaim St. 107**

**Tel Aviv-Yafo, Israel**

**Tel: +972-73-7969804, ext. 200**

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

**INFORMATION CONTAINED IN THIS CURRENT REPORT ON FORM 6-K**

On August 10, 2025, Arbe Robotics Ltd. posted a notice of the 2025 annual general meeting on its website. A copy of the notice is furnished as Exhibit 99.1 to this Form 6-K.

**<u>Exhibit Index</u>**

---

| | |
|:---|:---|
| **Exhibit No.** | **Document Description** |
| 99.1 | [Notice of Annual General Meeting](ea025273201ex99-1_arberobot.htm) |

---

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **ARBE ROBOTICS LTD.** | **ARBE ROBOTICS LTD.** |
| Date: August 11, 2025 | By: | /s/ Kobi Marenko |
|  | Name: | Kobi Marenko |
|  | Title: | CEO |

---

## Exhibit 99.1

**Exhibit 99.1**

![Icon Description automatically generated](image_001.jpg)

**ARBE ROBOTICS LTD**

**107 HaHashmonaim St., Tel Aviv-Yafo, Israel**

**NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS**

Dear Arbe Shareholders:

We cordially invite you to attend our 2025 Annual General Meeting of Shareholders of Arbe Robotics Ltd., or the Company, to be held at 16:00 (Israel time), which is 9:00 AM Eastern Daylight Time, on Wednesday, September 17, 2025. The meeting will solely be held virtually via videoconference at https://www.cstproxy.com/arberobotics/2025, and without physical presence of shareholders or their representatives. You can attend the Meeting as a guest or by entering your 12-digit control number as set forth in your proxy card, in order to submit questions and vote online.

It is proposed that at the meeting, the shareholders adopt resolutions for the following purposes:

&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Election of Class I Directors</u>: Election of each of Dr. Noam Arkind and Mr. Chris Van
Dan Elzen as Class I directors of the Company, to serve approximately three years until the Company's annual general meeting of
shareholders to be held in 2028 and until their respective successors are duly elected, and the approval the compensation terms of Mr.
Chris Van Dan Elzen.

&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Executives Directors' Compensation</u>: Approval of a special one-time grant to each of
(a) Mr. Kobi Marenko, the Company's Chief Executive Officer and a member of the Board, and (b) Dr. Noam Arkind, the Company's
Chief Technology Officer and a member of the Board, comprising of equity-based award and cash bonus, with both components subject to
continued service of the Company, to be vested on April 1, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Non-Executive Directors' Compensation</u>: Approval of an equity-based award to each of
(a) Dr. Boaz Schwartz, a member of the Board, and (b) Thilo Koslowski, a member of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Re-appointment of Independent Auditors</u>: Approval of the re-appointment of Somekh Chaikin,
a registered public accounting firm, a member firm of KPMG International, as the Company's independent registered public accounting
firm for the year ending December 31, 2025, and until the Company's 2026 annual general meeting of shareholders, and to authorize
the Audit Committee and/or Board to fix such accounting firm's annual compensation.

&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Registered Share Capital Increase</u>: To approve an increase of the Company's registered
(authorized) share capital by an additional NIS 7,560, which consists of 35,000,000 ordinary shares par value NIS 0.000216 each, to a
total of 200,000,000 ordinary shares.

Members of the Company's management will be available at the meeting to discuss the Company's audited financial statements for the year ended December 31, 2024.

The Board recommends that you vote in favor of each of the proposals, which will be more fully described in the Company's proxy statement, to be filed prior to the meeting.

We know of no matters to be submitted at the meeting other than as specified herein.

The record date for the meeting is August 15, 2025. Only shareholders of record at the close of business on that date are entitled to notice of and to vote at the meeting or any adjournments, postponements, or continuations thereof.

Information as to attendance at the meeting and the voting procedures will be set forth in the Company's proxy statement, which, together with the proxy card, will be made available to shareholders and posted on the Company's website in advance of the meeting and through its public filings. To assure your representation at the Meeting, please vote your proxy via the internet, by email, or by completing, dating, signing and returning the enclosed proxy.

Thank you for your ongoing support of, and continued interest in Arbe.

Sincerely,

**Yair Shamir**

**Chairman of the Board**

**Kobi Marenko**

**Chief Executive Officer** 

August 10, 2025